Noncanonical role of ALAS1 as a heme-independent inhibitor of small RNA-mediated silencing Journal Article


Authors: Lee, S.; Lee, S.; Desnick, R.; Yasuda, M.; Lai, E. C.
Article Title: Noncanonical role of ALAS1 as a heme-independent inhibitor of small RNA-mediated silencing
Abstract: microRNAs (miRNAs) and small interfering RNAs (siRNAs) are 21- to 22-nucleotide RNAs that guide Argonaute-class effectors to targets for repression. In this work, we uncover 5-aminolevulinic acid synthase 1 (ALAS1), the initiating enzyme for heme biosynthesis, as a general repressor of miRNA accumulation. Although heme is known to be a positive cofactor for the nuclear miRNA processing machinery, ALAS1-but not other heme biosynthesis enzymes-limits the assembly and activity of Argonaute complexes under heme-replete conditions. This involves a cytoplasmic role for ALAS1, previously considered inactive outside of mitochondria. Moreover, conditional depletion of ALAS activity from mouse hepatocytes increases miRNAs and enhances siRNA-mediated knockdown. Notably, because ALAS1 is the target of a Food and Drug Administration-approved siRNA drug, agents that suppress ALAS may serve as adjuvants for siRNA therapies.
Keywords: genetics; mouse; animal; metabolism; animals; mice; hepatocytes; microrna; small interfering rna; rna, small interfering; rna interference; liver cell; micrornas; argonaute protein; hek293 cells; heme; argonaute proteins; humans; human; hek293 cell line; 5 aminolevulinate synthase; 5-aminolevulinate synthetase; alas1 protein, human
Journal Title: Science
Volume: 386
Issue: 6728
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2024-12-20
Start Page: 1427
End Page: 1434
Language: English
DOI: 10.1126/science.adp9388
PUBMED: 39700288
PROVIDER: scopus
PMCID: PMC11829814
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric C Lai
    159 Lai
  2. Seungjae Lee
    8 Lee